OBJECTIVE: Neurocognitive impairment was found to be heritable in individuals with schizophrenia and their relatives. However, the heritability of neurocognitive measures in families with and without schizophrenia has not been directly compared. In this study, we examined the genetic structure of clinical and neurocognitive measures in sibling pairs with and without schizophrenia to test the hypothesis that the familial aggregation of such measures may be altered by having schizophrenia. METHOD: A total of 278 subjects including patients with schizophrenia and their non-psychotic full siblings, healthy controls, and their full siblings were recruited. Heritability was estimated for working memory, episodic memory, executive function and attention, as well as clinical features, such as positive, negative and disorganization symptoms. RESULTS: Many clinical and cognitive domains were impaired in subjects with schizophrenia and their non psychotic siblings. Negative symptoms, working memory, episodic memory and executive function, but not positive, disorganization symptoms and attention, were found to be significantly heritable in all sibling pairs. However, the heritability of working memory function was significantly (chi(2)((d.f.=6))=13.9, p=.031) decreased in proband sibling pairs (h(2)=.38) as compared to control sibling pairs (h(2)=.95). Significant genetic correlations were observed between negative symptoms and the cluster of working memory, episodic memory and executive function. CONCLUSIONS: Several neurocognitive measures were heritable in sibling pairs with and without schizophrenia. However, schizophrenia reduced the heritability of working memory, perhaps due to disease-related environmental or genetic factors. Evidence for potential pleiotropy will inform future phenotypic studies.
OBJECTIVE:Neurocognitive impairment was found to be heritable in individuals with schizophrenia and their relatives. However, the heritability of neurocognitive measures in families with and without schizophrenia has not been directly compared. In this study, we examined the genetic structure of clinical and neurocognitive measures in sibling pairs with and without schizophrenia to test the hypothesis that the familial aggregation of such measures may be altered by having schizophrenia. METHOD: A total of 278 subjects including patients with schizophrenia and their non-psychotic full siblings, healthy controls, and their full siblings were recruited. Heritability was estimated for working memory, episodic memory, executive function and attention, as well as clinical features, such as positive, negative and disorganization symptoms. RESULTS: Many clinical and cognitive domains were impaired in subjects with schizophrenia and their non psychotic siblings. Negative symptoms, working memory, episodic memory and executive function, but not positive, disorganization symptoms and attention, were found to be significantly heritable in all sibling pairs. However, the heritability of working memory function was significantly (chi(2)((d.f.=6))=13.9, p=.031) decreased in proband sibling pairs (h(2)=.38) as compared to control sibling pairs (h(2)=.95). Significant genetic correlations were observed between negative symptoms and the cluster of working memory, episodic memory and executive function. CONCLUSIONS: Several neurocognitive measures were heritable in sibling pairs with and without schizophrenia. However, schizophrenia reduced the heritability of working memory, perhaps due to disease-related environmental or genetic factors. Evidence for potential pleiotropy will inform future phenotypic studies.
Authors: M Wright; E De Geus; J Ando; M Luciano; D Posthuma; Y Ono; N Hansell; C Van Baal; K Hiraishi; T Hasegawa; G Smith; G Geffen; L Geffen; S Kanba; A Miyake; N Martin; D Boomsma Journal: Twin Res Date: 2001-02
Authors: T D Cannon; M O Huttunen; J Lonnqvist; A Tuulio-Henriksson; T Pirkola; D Glahn; J Finkelstein; M Hietanen; J Kaprio; M Koskenvuo Journal: Am J Hum Genet Date: 2000-07-03 Impact factor: 11.025
Authors: Gabriëlla A M Blokland; Raquelle I Mesholam-Gately; Timothea Toulopoulou; Elisabetta C Del Re; Max Lam; Lynn E DeLisi; Gary Donohoe; James T R Walters; Larry J Seidman; Tracey L Petryshen Journal: Schizophr Bull Date: 2017-07-01 Impact factor: 9.306
Authors: Katherine H Karlsgodt; Peter Bachman; Anderson M Winkler; Carrie E Bearden; David C Glahn Journal: Behav Brain Res Date: 2011-08-22 Impact factor: 3.332
Authors: W C Hochberger; T Combs; J L Reilly; J R Bishop; R S E Keefe; B A Clementz; M S Keshavan; G D Pearlson; C A Tamminga; S K Hill; J A Sweeney Journal: Schizophr Res Date: 2017-05-22 Impact factor: 4.939
Authors: Katherine H Karlsgodt; Peter Kochunov; Anderson M Winkler; Angela R Laird; Laura Almasy; Ravindranath Duggirala; Rene L Olvera; Peter T Fox; John Blangero; David C Glahn Journal: J Neurosci Date: 2010-06-16 Impact factor: 6.167
Authors: Joseph J Shenker; Sarojini M Sengupta; Ridha Joober; Ashok Malla; M Mallar Chakravarty; Martin Lepage Journal: J Psychiatry Neurosci Date: 2017-05 Impact factor: 6.186
Authors: Huiping Zhang; Henry R Kranzler; James Poling; Jeffrey R Gruen; Joel Gelernter Journal: Neuropsychopharmacology Date: 2009-07-15 Impact factor: 7.853
Authors: Monica E Calkins; Amrita Ray; Ruben C Gur; Robert Freedman; Michael F Green; Tiffany A Greenwood; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Catherine Sugar; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff; Laura C Lazzeroni; Raquel E Gur Journal: Biol Psychiatry Date: 2013-02-08 Impact factor: 13.382